United States · FDA National Drug Code directory
Nelarabine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43598-142_8105c460-afd8-5eec-7857-c2e4e5b89fc3
- Product NDC
- 43598-142
- Form
- INJECTION
- Composition / generic term
- Nelarabine
- Labeler
- Dr. Reddy's Laboratories, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230109
- Source listing expiry
- 20261231
Source-listed ingredients
- NELARABINE — 5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 6 VIAL, SINGLE-DOSE in 1 CARTON (43598-142-06) / 50 mL in 1 VIAL, SINGLE-DOSE · 43598-142-06
- 1 VIAL, SINGLE-DOSE in 1 CARTON (43598-142-11) / 50 mL in 1 VIAL, SINGLE-DOSE · 43598-142-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →